Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. Klement P, Fiedler W, Gabdoulline R, Dallmann LK, et al. Ann Hematol 2023;102:323-328.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Klement P, Fiedler W, Gabdoulline R, Dallmann LK, et al. Molecular response patterns in relapsed/refractory AML patients treated with selinexor and chemotherapy. Ann Hematol 2023;102:323-328.
PMID: 36576532